Olivera Bozickovic's picture

Olivera Bozickovic

Staff Engineer

Biobank coordinator for gynecological cancers, MoMaTEC2.

Academic article
  • 2020. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. Gynecologic Oncology. 1-9.
  • 2018. A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology. 57-70.
  • 2015. The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells. PLOS ONE. 19 pages.
  • 2015. Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2). Scientific Reports.
  • 2015. Cyclin C interacts with steroid receptor coactivator 2 and upregulates cell cycle genes in MCF-7 cells. BBA - Molecular Cell Research. 2383-2391.
  • 2013. cAMP response element-binding protein interacts with and stimulates the proteasomal degradation of the nuclear receptor coactivator GRIP1. Endocrinology. 1513-1527.
Doctoral dissertation
  • 2015. Regulation and function of steroid receptor coactivator 2 in hepatoma and breast cancer cells.
  • 2016. Repression of liver SRC-2 by metformin inhibits glucose, lipid and cholesterol biosynthesis.
  • 2014. Steroid receptor coactivators during short-term estrogen deprivation.

More information in national current research information system (CRIStin)

PhD, University of Bergen.

Master degree in Molecular biology, University of Bergen.

Diploma in Molecular biology, University of Zagreb.